Baiyunshan: A subsidiary Guangzhou Pharmaceuticals will be listed on the New Third Board.

On the evening of May 19, Baiyunshan announced that the company recently received a notification from its holding subsidiary, Guangzhou Pharmaceutical Co., Ltd., stating that Guangzhou Pharmaceutical's stock will be listed and publicly traded on the National Equities Exchange and Quotations system starting on May 20, 2025.